Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome

Leonardo Restivo1, Francesca Ferrari1, Enrica Passino1, Carmelo Sgobio1, Jörg Bock1, Ben A. Oostra1, Claudia Bagni1, Martine Ammassari‐Teule1
1Laboratory of Psychobiology, Consiglio Nazionale delle Ricerche Institute of Neuroscience, 00179 Rome, Italy; Department of Experimental Neurology, Fondazione Santa Lucia, Istituto Ricovero e Cura a Carattere Scientifico, 00179 Rome, Italy; Institute of Biology, Department of Zoology and Developmental Neurobiology, Otto-von-Guericke University, 39118 Magdeburg, Germany; Department of Clinical Genetics, Erasmus Medical Center, 3015 GE Rotterdam, The Netherlands; and Department of Biology, University...

Tóm tắt

Fragile X syndrome, the most frequent form of hereditary mental retardation, is due to a mutation of the fragile X mental retardation 1 ( FMR1 ) gene on the X chromosome. Like fragile X patients, FMR1 -knockout ( FMR1 -KO) mice lack the normal fragile X mental retardation protein (FMRP) and show both cognitive alterations and an immature neuronal morphology. We reared FMR1 -KO mice in a C57BL/6 background in enriched environmental conditions to examine the possibility that experience-dependent stimulation alleviates their behavioral and neuronal abnormalities. FMR1 -KO mice kept in standard cages were hyperactive, displayed an altered pattern of open field exploration, and did not show habituation. Quantitative morphological analyses revealed a reduction in basal dendrite length and branching together with more immature-appearing spines along apical dendrites of layer five pyramidal neurons in the visual cortex. Enrichment largely rescued these behavioral and neuronal abnormalities while increasing α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor subunit 1 (GluR1) levels in both genotypes. Enrichment did not, however, affect FMRP levels in the WT mice. These data suggest that FMRP-independent pathways activating glutamatergic signaling are preserved in FMR1 -KO mice and that they can be elicited by environmental stimulation.

Từ khóa


Tài liệu tham khảo

10.1542/peds.97.1.122

10.1016/S0959-437X(02)00299-X

10.1146/annurev.neuro.25.112701.142909

10.1097/00008480-200312000-00003

Zalfa, F. & Bagni, C. (2004) Curr. Issues Mol. Biol. 6, 73-88.15119819

10.1126/science.7692601

10.1038/ng0193-36

Bakker, C. E., Verheij, C., Willemsen, R., Vanderhelm, R., Oerlemans, F., Vermey, M., Bygrace, A., Hoogeveen, A. T., Oostra, B. A., Reyniers, E., et al. (1994) Cell 78, 23-33.8033209

10.1002/hipo.10005

10.1073/pnas.94.10.5401

10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B

10.1002/ajmg.10500

10.1523/JNEUROSCI.21-14-05139.2001

10.1016/S0006-8993(03)02363-1

10.1073/pnas.141145998

10.1073/pnas.2336265100

10.1126/science.290.5495.1364

10.1113/jphysiol.2002.031369

10.1006/mcne.2001.1085

10.1073/pnas.122205699

Hebb, D. O. (1947) Am. Psychol. 2, 306-307.

10.1037/h0045402

10.1111/j.1460-9568.2004.03587.x

10.1016/S0091-3057(02)00790-6

10.1111/j.1460-9568.2003.03032.x

10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#

10.1016/0014-4886(73)90278-1

10.1093/cercor/10.10.1038

Diamond, M. C. & Connor, J. R., Jr. (1982) Exp. Brain Res. 5, 36-44.7151919

10.1016/0006-8993(85)90525-6

10.1073/pnas.97.23.12880

10.1002/(SICI)1098-1063(1999)9:3<321::AID-HIPO11>3.0.CO;2-C

10.1006/exnr.2000.7415

10.1016/S0031-9384(01)00543-1

10.1016/S0197-4580(02)00138-0

10.1016/j.nlm.2004.02.002

10.1016/S0006-8993(01)03309-1

10.1016/0165-0270(81)90045-5

10.1016/S0165-0270(97)00163-5

10.1016/0165-0270(86)90116-0

Horner, C. H. & Arbuthnott, E. (1991) J. Anat. 177, 179-184.1769892

10.1016/S0092-8674(03)00079-5

10.1073/pnas.242377399

10.1093/hmg/9.6.901

10.1016/S0165-3806(02)00642-9

10.1007/s002130050038

10.1006/nlme.1999.3914

10.1523/JNEUROSCI.2185-04.2004

10.1038/78791

10.1038/nature01781

10.1523/JNEUROSCI.22-18-08042.2002

10.1016/S0006-8993(98)00451-X

10.1196/annals.1296.032

Danysz, W. (2002) Curr. Opin. Investig. Drugs 3, 1081-1088.12186271

10.1002/(SICI)1096-8628(19990402)83:4<248::AID-AJMG3>3.0.CO;2-1

10.1523/JNEUROSCI.0099-04.2004

10.1126/science.287.5461.2262

10.1542/peds.108.5.e88

10.1097/00004583-200203000-00002